Skip to main content
. 2022 Mar 17;12:861078. doi: 10.3389/fonc.2022.861078

Figure 3.

Figure 3

Detection of ATRX loss by immunohistochemistry and NGS. (A) Retained nuclear expression of ATRX in neoplastic glioma cells (immunoperoxidase; original magnification 200x). (B) Loss of nuclear expression of ATRX in a sample of astrocytoma (case 49) (left panel). Note the retained immunoreactivity in endothelial cells and non-neoplastic entrapped glial cells (immunoperoxidase; original magnification 200x). NGS demonstrated the presence of the ATRX p. Lys329IlefsTer3 truncated mutation (case 49) (right panel). Results were viewed in the IGV.